PDF Cover

Coronary Atherectomy Devices Market

The market for Coronary Atherectomy Devices was estimated at $1.2 billion in 2024; it is anticipated to increase to $1.9 billion by 2030, with projections indicating growth to around $2.9 billion by 2035.

Report ID:DS1801200
Author:Debadatta Patel - Senior Consultant
Published Date:
Datatree
Life Science
Medical Device
Coronary Atherectomy Devices
Share
Connect
Report Price: $4,200
Report Summary
Market Data
Methodology
Table of Contents

Global Coronary Atherectomy Devices Market Outlook

Revenue, 2024

$1.2B

Forecast, 2034

$2.6B

CAGR, 2025 - 2034

8.1%

The Coronary Atherectomy Devices industry revenue is expected to be around $1.3 billion in 2025 and expected to showcase growth with 8.1% CAGR between 2025 and 2034. The importance of Coronary Atherectomy Devices in the field of healthcare is significant due to the rising prevalence of heart related diseases on a scale recently. It is concerning that heart conditions have become one of the causes of death worldwide in recent times. The importance of these devices is highlighted by their role in clearing arterial blockages and lowering the risk of heart attacks which ultimately helps in saving lives. Their role as medical tools, in Intensive Care Units and emergency procedures cannot be understated. In this scenario​t the main factors propelling this market forward are increasing healthcare costs​g evolving advancements​s and a growing awareness of heart health, among people worldwide​e.

Specialized medical tools known as Coronary Atherectomy Devices are commonly utilized in Percutaneous Coronary Intervention procedures to address plaque accumulation within the arteries and improve blood flow to the hearts normal state. This equipment is frequently combined with stents and balloons in coronary interventions to ensure the best possible results, for patients.

Coronary Atherectomy Devices market outlook with forecast trends, drivers, opportunities, supply chain, and competition 2024-2034
Coronary Atherectomy Devices Market Outlook

Market Key Insights

  • The Coronary Atherectomy Devices market is projected to grow from $1.2 billion in 2024 to $2.6 billion in 2034. This represents a CAGR of 8.1%, reflecting rising demand across Percutaneous Coronary Intervention (PCI), Chronic Total Occlusions (CTO), and In-Stent Restenosis (ISR).

  • Boston Scientific, Medtronic Plc, and Philips NV are among the leading players in this market, shaping its competitive landscape.

  • U.S. and Germany are the top markets within the Coronary Atherectomy Devices market and are expected to observe the growth CAGR of 5.9% to 8.5% between 2024 and 2030.

  • Emerging markets including Brazil, India and UAE are expected to observe highest growth with CAGR ranging between 7.8% to 10.1%.

  • Transition like Technological Innovations is expected to add $170 million to the Coronary Atherectomy Devices market growth by 2030

    .

  • The Coronary Atherectomy Devices market is set to add $1.4 billion between 2024 and 2034, with manufacturer targeting Ambulatory Surgical Centers & Hospitals Application projected to gain a larger market share.

  • With

    rising incidence of cardiovascular diseases, and

    Technological Advancements in Atherectomy Devices, Coronary Atherectomy Devices market to expand 118% between 2024 and 2034.

coronary atherectomy devices market size with pie charts of major and emerging country share, CAGR, trends for 2025 and 2032
Coronary Atherectomy Devices - Country Share Analysis

Opportunities in the Coronary Atherectomy Devices

Establishment of alliances and partnerships between companies producing medical devices and healthcare organizations or research institutions has also the potential to accelerate the adoption of coronary atherectomy devices in the market significantly. These collaborations play a role, in promoting information exchange and fostering the creation of cutting edge and effective products.

Growth Opportunities in North America and Asia-Pacific

In North America's healthcare sector is witnessing a growth in the market for Coronary Atherectomy Devices owing to the rising demand for advanced cardiovascular treatments driven by the increasing cases of coronary artery diseases and well developed healthcare infrastructure in the region The continuous advancements in cardiology equipment, by key industry players are also contributing to the expansion of the market. Favorable reimbursement policies from Medicare and Medicaid in the United States have played a role in driving market growth for atherectomy procedures. Competition among market players, in the region is fierce as they use marketing tactics and consistently improve their products to stay ahead.
In the Asia Pacific region there is growth in the market for Coronary Atherectomy Devices due to the increasing healthcare challenges caused by the rising cases of coronary artery disease in countries with dense populations such as India and China. The growing numbers of obesity and heart failure cases along with hypertension have also played a role in driving up the demand for Coronary Atherectomy Devices in these region's. Governments are prioritizing investments in healthcare facilities. Promoting technological advancements which are creating a favorable atmosphere, for the expansion of the market.

Market Dynamics and Supply Chain

01

Driver: Rising Incidence of Cardiovascular Diseases, and Demand Surge for Minimally Invasive Procedures

In the field of healthcare there has also been an increase in cases of heart related illnesses in recent times. The surge in these conditions has also called for an use of coronary atherectomy devices which are also designed to remove plaque from the arteries during certain procedures. This has also led to an expansion of the market as more people seek out less invasive options, in cardiology.

The growing popularity of invasive heart procedures in the field of cardiology plays a significant role in driving the market demand for coronary atherectomy devices as they align with the less invasive treatment strategy resulting in lower surgical risks and shorter hospital stays along, with quicker patient recuperation periods.

One key aspect of the coronary atherectomy devices market is also the continuous advancement of technology in the industry sector Market participants are also continuously working towards developing more advanced and intricate devices to achieve higher precision in procedures that are also less invasive and lead to improved post surgical results The ongoing progress in advanced technologies like rotational and directional coronary atherectomy devices has also been driving market growth by providing opportunities for enhanced patient care, in cardiovascular health.

02

Restraint: High Cost of Procedures

The high expenses linked to utilizing Coronary Atherectomy Devices significantly hinder market expansion opportunities due to reasons such as expensive device pricing and the need for skilled healthcare professionals to handle intricate procedures and post operative care requirements in a proficient manner. Making costly treatments less attainable for a demographic due to limited budget resources and financial limitations in less developed areas has a detrimental effect on the demand for these devices, in the market.

03

Opportunity: Untapped Emerging Markets and Technological Advancements in Device Design

The swift growth of cities and rising focus on healthcare in developing nations such as China, India and Brazil offer potential for the development of devices used in coronary atherectomy procedures. Marketplaces with a number of patients suffering from heart conditions provide opportunities, for the growth of atherectomy devices that have not only yet been fully explored. Creating marketing and distribution plans tailored to these markets can greatly increase the use of these devices and enhance overall sales.

Advancements in technology have led to significant progress in the development and features of devices used for coronary atherectomy procedures. Improvements focus on making these devices less invasive and easier to use while enhancing precision through innovations like drug coated balloons and rotational atherectomy tools. The market is anticipated to grow due, to these enhancements with companies investing in research and development for designs poised to stand out competitively.

04

Challenge: Lack of Awareness and Technological Adoption

Despite the advancements in technology a significant hurdle for the Coronary Atherectomy Devices market persists in regions with access to healthcare information and services. In remote areas both patients and healthcare providers lack awareness of new treatment options like atherectomy. Moreover the slow uptake of technology is hindered by challenges such as infrastructure, limited training opportunities for personnel and economic constraints. These factors collectively impede the expansion prospects of Coronary Atherectomy Devices, in these regions.

Supply Chain Landscape

1

Raw Material Suppliers

DuPontBASF SE
2

Device Manufacturers

Medtronic PlcBoston Scientific Corporation
3

Distributors & Suppliers

Cardinal HealthMcKesson Corporation
4

End Users

HospitalsAmbulatory Surgical CentersCardiology Clinics
Coronary Atherectomy Devices - Supply Chain

Use Cases of Coronary Atherectomy Devices in Percutaneous Intervention (PCI) & In-Stent Restenosis (ISR)

Percutaneous Coronary Intervention (PCI) : Coronary Atherectomy Devices play a role in Percutaneous Coronary Intervention by removing blockages in the coronary arteries caused by atherosclerotic plaque buildup. One common technique used is rotablation atherectomy which involves using a speed rotational device to remove plaque and improve blood flow without causing harm to healthy tissues. Leading companies in this field, like Medtronic and Boston Scientific have advanced atherectomy technology that keeps them at the forefront of the market through product innovation and expanding their reach.
Chronic Total Occlusions (CTO) : Chronic Total Occlusions refer to arteries that are completely blocked as a result of hardened plaque accumulation over an extended period of time. Medical devices like orbital atherectomy and laser atherectomy tools are employed to clear these blockages and improve blood circulation. Companies such, as Philips are known for their equipment tailored for Chronic Total Occlusions treatment; for instance the Excimer Laser Atherectomy device utilizes laser energy to dissolve the plaque and widen the affected region effectively.
In-Stent Restenosis (ISR) : In Stent Restrenosis involves the narrowing of a stent that was previously inserted in the bodys arteries or veins. Then coronary atherectomy devices such as atherectomy devices are used to delicately remove the narrowed portion, within the stent.

Recent Developments

The market for Coronary Atherectomy Devices worldwide is seeing progress due to advancements in medical device technology that have greatly enhanced invasive cardiac procedures using these devices known for their effectiveness, in treating complex coronary artery diseases Additionally the rising prevalence of cardiovascular conditions globally is a key trend impacting this market.

December 2024 : Boston Scientific Corporation introduced a version of their rotational coronary atherectomy devices that provide enhanced precision and control when clearing plaque from arteries.
October 2024 : Medtronic PLC broadened its range of products by launching a minimally invasive coronary atherectomy device to improve patient care and speed up recovery times.
August 2024 : Abbott Laboratories launched a study to test their innovative laser equipment for treating complex coronary artery disease. The goal is to gather proof of the treatments safety and efficacy in challenging cases.

Impact of Industry Transitions on the Coronary Atherectomy Devices Market

As a core segment of the Medical Device industry, the Coronary Atherectomy Devices market develops in line with broader industry shifts. Over recent years, transitions such as Technological Innovations and Regulatory Compliance have redefined priorities across the Medical Device sector, influencing how the Coronary Atherectomy Devices market evolves in terms of demand, applications and competitive dynamics. These transitions highlight the structural changes shaping long-term growth opportunities.
01

Technological Innovations

The Coronary Atherectomy Devices market is undergoing a significant transformation, shifting from a primary focus on lesion removal to a comprehensive approach that enhances vessel preparation through advanced technologies. Innovations such as orbital rotation and laser atherectomy are not only redefining treatment methodologies but also expanding the spectrum of interventional cardiology procedures. This strategic pivot is projected to drive market growth by an impressive $190 million by 2030, underscoring the critical role of technological advancements in shaping the future of cardiovascular interventions. As these devices evolve, they promise to enhance patient outcomes and solidify their position within the broader cardiology landscape. This industry transition is expected to add $170 million in the industry revenue between 2024 and 2030.
02

Regulatory Compliance

The stringent regulations surrounding the creation and authorization of tools for atherectomy have undergone a notable shift recently. Companies are increasingly focusing on conducting trials and research to secure approvals from regulatory bodies like the FDA and CE mark to showcase the safety and effectiveness of their devices. This proactive approach has had an impact, on the medical devices sector by facilitating the introduction of top notch coronary atherectomy devices that are both efficient and safe.

Related Reports
Loading related reports...